What does TOMI Environmental do and what are its main business segments?

What is the revenue and EPS growth rate for TOMI Environmental year over year?

What were the key takeaways from TOMI Environmental’s earnings call?

Did TOMI Environmental beat or miss consensus estimates last quarter?

What factors drove the changes in TOMI Environmental's revenue and profit?

What is TOMI Environmental's gross profit margin?

What is the market's earnings forecast for TOMI Environmental next quarter?

What guidance did TOMI Environmental's management provide for the next earnings period?

- **Revenue Recovery**: Q3 2025 revenue up 95% sequentially to $2 million, driven by BIT Solution sales (21% YTD growth) and equipment purchases.
- **FDA Breakthrough**: Hydrogen peroxide approval for food safety opens $3+ billion RTE market; direct food surface disinfection now possible.
- **Strategic Capital**: $20M equity purchase agreement provides funding flexibility for 2026 growth initiatives.
- **Key Wins**: New customers include Bausch & Lomb, Nestle, and major pharma companies; $3M custom automation pipeline.
- **Gross Margin Resilience**: 61% gross margin maintained despite 24% YoY revenue decline.

**【CEO Summary Section】**
- Q3 2025 revenue reached $2 million, a 95% sequential increase driven by recurring BIT Solution sales (up 21% YTD) and capital equipment purchases from service providers.
- Sales backlog grew to $1.3 million by end of October, with $3 million in pending SteraMist Integration Contracts expected to close by year-end.
- FDA approval of hydrogen peroxide for food safety opens new markets, including RTE (ready-to-eat) food processing and transportation.
- Strategic partnership with Hudson Global Ventures provides $20 million equity purchase flexibility for scaling initiatives.

**【CFO Financial Commentary】**
- Q3 2025 revenue ($2 million) declined 24% YoY due to delayed iHP services from a key customer, but year-to-date service demand rose 35% in life sciences/food safety.
- Gross margin remained strong at 61%, while operating loss was $320,000 vs. $149 million profit in Q3 2024.
- Cash reserves of $190,000 and working capital of $2.5 million support near-term operations.

**【COO Business Highlights】**
- New customers include Bausch & Lomb (eye health) and Nestle (food safety), with SteraMist deployments across 20+ countries.
- FDA approval enables direct food surface disinfection, targeting RTE food processing, packaging, and transportation.
- Pharmaceutical industry adoption growing with SteraMist Integrated Systems (SIS) for bioprocessing automation.
- $3 million pipeline in custom automation solutions for 2025 close.

**【Q&A Highlights】**
- **Food Safety Expansion**: FDA approval validation efforts underway with major food processors; initial focus on RTE, prepackaged meals, and transportation.
- **Military & Defense**: Engaged with U.S. military on formaldehyde replacement studies; expects 2026 deal.
- **Data Center Market**: Exploring partnerships for large-scale facility disinfection; sales team expansion planned.
- **Medical Sterilization**: Testing SteraMist as ethylene oxide alternative for medical device sterilization.
- **Operating Expenses**: Expect revenue growth to outpace expense increases, maintaining ~60% gross margin.

TOMI Environmental Solutions, Inc. (TOMZ) Q3 2025 Earnings Call Transcript

Revenue

Sales and Services Revenue

Financing Services Revenue

Other Revenue

Cost of Revenue

Cost of Goods and Services

Cost of Financing Services

Other Cost

Gross Profit

Other Operating Income

Operating Expenses

Selling, General and Administrative Expenses

Selling and Marketing Expenses

General and Administrative Expenses

Research and Development Expenses

Loss on Bad Debts

Loss on Impairment of Other Assets

Loss on Disposal of Assets

Other Operating Expenses

Operating Income

Non-Operating Income (Loss)

Income (Loss) from Affiliates

Income (Loss) from Associates

Income (Loss) from Joint ventures

Gain (Loss) on Other Investment

Gain (Loss) on Change in Fair Value

Gain (Loss) on Foreign Currency Exchange

Other Non-Operating Income (Loss)

Net Interest Expense

Interest Expense

Interest Income

Pretax Income From Continuing Operations

Income Tax Expense

Current Income Tax

Deferred Income Tax

Income Tax Adjustments

Net Income from Continuing Operations

Income from Discontinued Operations

Other Items Before Net Income

Net Income

Net Income Attributable to Minority Interests

Net Income Attributable to Owners of the Company

Preferred Stock Dividends

Other Adjustments

Net Income Attributable to Common Stockholders

Other Comprehensive Income

Total Comprehensive Income

Total Comprehensive Income Attributable to Minority Interests

Total Comprehensive Income Attributable to Owners of the Company

Basic EPS

Basic EPS from Continuing Operations

Basic EPS from Discontinued Operations

Diluted EPS

Diluted EPS from Continuing Operations

Diluted EPS from Discontinued Operations

TOMZ

TOMZ fundamentals

You can ask Aime